Constellation Brands Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Feb 28, 2026 · FY), Constellation Brands Inc reported revenue of $9.8B (-11.0% year on year) and net income of $1.8B (+5748.9% year on year).
| Line item | Feb 28, 2026 · FY | Feb 28, 2025 · FY | Feb 29, 2024 · FY | Feb 28, 2023 · FY |
|---|---|---|---|---|
| Sales | $9.8B | $11.0B | — | — |
| Excise taxes | ($616.5M) | ($748.2M) | — | — |
| Net sales | $9.1B | $10.2B | — | — |
| Cost of product sold | ($4.4B) | ($4.9B) | — | — |
| Gross profit | $4.7B | $5.3B | — | — |
| Selling, general, and administrative expenses | ($1.8B) | ($1.9B) | — | — |
| Goodwill and intangible assets impairment | $0 | ($2.8B) | — | — |
| Asset impairment and related expenses | ($109.8M) | — | — | — |
| Gain (loss) on sale of business | ($31.9M) | $266.0M | — | — |
| Operating income (loss) | $2.7B | $354.9M | — | — |
| Income (loss) from unconsolidated investments | $9.0M | ($26.3M) | — | — |
| Interest expense, net | ($352.6M) | ($411.4M) | — | — |
| Income (loss) before income taxes | $2.4B | ($82.8M) | — | — |
| (Provision for) benefit from income taxes | ($621.0M) | $51.7M | — | — |
| Net income (loss) | $1.8B | ($31.1M) | — | — |
| Net (income) loss attributable to noncontrolling interests | ($70.1M) | ($50.3M) | — | — |
| Net income (loss) attributable to CBI | $1.7B | ($81.4M) | — | — |
| Basic (in dollars per share) | $9.62 | -$0.45 | — | — |
| Diluted (in dollars per share) | $9.61 | -$0.90 | — | — |
| Basic (in shares) | 175.4M | 181.5M | — | — |
| Diluted (in shares) | 175.6M | 181.5M | — | — |
| Cash dividends declared per common share (in dollars per share) | $4.08 | $4.04 | — | — |
| Line item | Aug 31, 2026 · Q2 | May 31, 2026 · Q1 | Nov 30, 2025 · Q3 | Aug 31, 2025 · Q2 |
|---|---|---|---|---|
| Sales | $2.8B | $2.6B | $2.4B | — |
| Excise taxes | ($183.7M) | ($157.7M) | ($151.6M) | — |
| Net sales | $2.6B | $2.4B | $2.2B | — |
| Cost of product sold | ($1.2B) | ($1.1B) | ($1.0B) | — |
| Gross profit | $1.4B | $1.3B | $1.2B | — |
| Selling, general, and administrative expenses | ($538.2M) | ($457.0M) | ($491.2M) | — |
| Asset impairment and related expenses | ($49.8M) | ($18.3M) | $0 | — |
| Operating income (loss) | $805.0M | $845.3M | $692.0M | — |
| Income (loss) from unconsolidated investments | $7.8M | $500.0K | $23.5M | — |
| Interest expense, net | ($83.4M) | ($85.8M) | ($83.2M) | — |
| Income (loss) before income taxes | $729.4M | $760.0M | $632.3M | — |
| (Provision for) benefit from income taxes | ($147.1M) | ($88.1M) | ($110.1M) | — |
| Net income (loss) | $582.3M | $671.9M | $522.2M | — |
| Net (income) loss attributable to noncontrolling interests | ($16.5M) | ($18.1M) | ($19.4M) | — |
| Net income (loss) attributable to CBI | $565.8M | $653.8M | $502.8M | — |
| Comprehensive income (loss) | $740.8M | $583.1M | $617.9M | — |
| Comprehensive (income) loss attributable to noncontrolling interests | ($23.3M) | ($14.7M) | ($23.6M) | — |
| Comprehensive income (loss) attributable to CBI | $717.5M | $568.4M | $594.3M | — |
| Net income (loss) per common share attributable to CBI - basic (in dollars per share) | $3.32 | $3.80 | $2.88 | — |
| Net income (loss) per common share attributable to CBI - diluted (in dollars per share) | $3.32 | $3.79 | $2.88 | — |
| Weighted average common shares outstanding - basic (in shares) | 170.5M | 172.2M | 174.5M | — |
| Weighted average common shares outstanding - diluted (in shares) | 170.6M | 172.4M | 174.6M | — |
| Cash dividends declared per common share (in dollars per share) | $1.03 | $1.03 | $1.02 | — |
| Line item | Feb 28, 2026 · FY | Feb 28, 2025 · FY | Feb 29, 2024 · FY | Feb 28, 2023 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $102.4M | $68.1M | $152.4M | $133.5M |
| Accounts receivable | $658.2M | $736.5M | $832.8M | $901.6M |
| Inventories | $1.4B | $1.4B | $2.1B | $1.9B |
| Prepaid expenses and other | $711.8M | $561.1M | $666.0M | $562.3M |
| Assets held for sale | $0 | $913.5M | — | — |
| Total current assets | $2.9B | $3.7B | $3.7B | $3.5B |
| Property, plant, and equipment, net | $8.5B | $7.4B | $8.1B | $6.9B |
| Goodwill | $5.2B | $5.1B | $8.0B | $7.9B |
| Intangible assets | $2.5B | $2.5B | $2.7B | $2.7B |
| Deferred income taxes | $1.4B | $1.8B | $2.1B | $2.2B |
| Other assets | $1.3B | $1.1B | $969.4M | $697.7M |
| Total assets | $21.9B | $21.7B | $25.7B | $24.7B |
| Short-term borrowings | $272.0M | $806.7M | $241.4M | $1.2B |
| Current maturities of long-term debt | $603.6M | $1.4B | $956.8M | $9.5M |
| Accounts payable | $960.2M | $939.8M | $1.1B | $941.5M |
| Other accrued expenses and liabilities | $854.0M | $886.7M | $836.4M | $852.0M |
| Total current liabilities | $2.7B | $4.0B | $3.1B | $3.0B |
| Long-term debt, less current maturities | $9.7B | $9.3B | $10.7B | $11.3B |
| Deferred income taxes and other liabilities | $1.1B | $1.2B | $1.8B | $1.7B |
| Total liabilities | $13.5B | $14.5B | $15.6B | $15.9B |
| Preferred Stock, $0.01 par value – Authorized, 1,000,000 shares; Issued, none | 0 | 0 | 0 | 0 |
| Common Stock, value | $2.1M | $2.1M | $2.1M | $2.1M |
| Additional paid-in capital | $2.2B | $2.1B | $2.0B | $1.9B |
| Retained earnings | $13.6B | $12.6B | $13.4B | $12.3B |
| Accumulated other comprehensive income (loss) | $423.2M | ($662.7M) | $376.8M | $28.5M |
| Class A Stock in treasury, at cost, 39,927,096 shares and 34,505,141 shares, respectively | -8.1B | -7.2B | -6.1B | — |
| Total CBI stockholders’ equity | $8.1B | $6.9B | $9.7B | $8.4B |
| Noncontrolling interests | $304.5M | $252.8M | $321.5M | $320.3M |
| Total stockholders’ equity | $8.4B | $7.1B | $10.1B | $8.7B |
| Total liabilities and stockholders’ equity | $21.9B | $21.7B | $25.7B | $24.7B |
| Line item | Aug 31, 2026 | May 31, 2026 | Nov 30, 2025 | Aug 31, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $98.5M | $96.6M | $152.4M | $72.0M |
| Accounts receivable | $678.1M | $726.7M | $708.3M | $667.6M |
| Inventories | $1.4B | $1.5B | $1.4B | $1.4B |
| Prepaid expenses and other | $804.3M | $765.1M | $669.2M | $699.6M |
| Total current assets | $3.0B | $3.0B | $2.9B | $2.9B |
| Property, plant, and equipment, net of accumulated depreciation of $3,254.7 and $3,095.1, respectively | $8.7B | $8.5B | — | — |
| Goodwill | $5.3B | $5.2B | $5.2B | $5.2B |
| Intangible assets | $2.5B | $2.5B | $2.5B | $2.5B |
| Deferred income taxes | $1.3B | $1.5B | $1.6B | $1.6B |
| Other assets | $1.3B | $1.3B | $1.3B | $1.2B |
| Total assets | $22.1B | $22.1B | $21.7B | $21.4B |
| Short-term borrowings | $116.5M | $336.3M | $374.7M | $252.5M |
| Current maturities of long-term debt | $1.1B | $1.1B | $4.0M | $504.1M |
| Accounts payable | $999.4M | $1.0B | $976.5M | $1.0B |
| Other accrued expenses and liabilities | $744.9M | $890.0M | $818.0M | $879.6M |
| Total current liabilities | $3.0B | $3.3B | $2.2B | $2.7B |
| Long-term debt, less current maturities | $9.1B | $9.1B | $10.3B | $9.8B |
| Deferred income taxes and other liabilities | $1.1B | $1.1B | $1.2B | $1.2B |
| Total liabilities | $13.2B | $13.6B | $13.7B | $13.6B |
| Common stock, value | $2.1M | $2.1M | $2.1M | $2.1M |
| Additional paid-in capital | $2.2B | $2.2B | $2.2B | $2.2B |
| Retained earnings | $14.4B | $14.1B | $13.6B | $13.2B |
| Accumulated other comprehensive income (loss) | $489.5M | $337.8M | ($800.0K) | ($92.3M) |
| Class A Stock in treasury | ($8.5B) | ($8.3B) | ($8.0B) | ($7.8B) |
| Total CBI stockholders’ equity | $8.6B | $8.3B | $7.7B | $7.5B |
| Noncontrolling interests | $292.5M | $294.2M | $289.5M | $285.9M |
| Total stockholders’ equity | $8.9B | $8.5B | $8.0B | $7.8B |
| Total liabilities and stockholders’ equity | $22.1B | $22.1B | $21.7B | $21.4B |
| Line item | Feb 28, 2026 · FY | Feb 28, 2025 · FY | Feb 29, 2024 · FY | Feb 28, 2023 · FY |
|---|---|---|---|---|
| Net income (loss) | $1.8B | ($31.1M) | $1.8B | ($38.5M) |
| Unrealized net (gain) loss on securities measured at fair value | $5.0M | $47.9M | $85.4M | $45.9M |
| Deferred tax provision (benefit) | $510.5M | ($210.3M) | $147.9M | $207.8M |
| Depreciation | $418.7M | $445.7M | $427.9M | $383.8M |
| Stock-based compensation | $67.7M | $72.2M | $63.6M | $68.5M |
| Equity in (earnings) losses of equity method investees and related activities, net of distributed earnings | ($2.5M) | ($5.4M) | $321.2M | $971.8M |
| Noncash lease expense | $127.4M | $112.4M | $91.3M | $89.3M |
| Equity method investments impairment | $1.5M | $8.7M | $136.1M | $1.1B |
| Asset impairment and related expenses | $109.8M | — | — | — |
| (Gain) loss on sale of business | $31.9M | ($266.0M) | — | — |
| Goodwill and intangible assets impairment | $0 | $2.8B | — | — |
| Accounts receivable | $82.9M | $90.3M | $73.2M | ($3.9M) |
| Inventories | ($48.3M) | ($152.2M) | ($182.3M) | ($356.4M) |
| Prepaid expenses and other current assets | $3.4M | ($89.4M) | ($76.5M) | $197.9M |
| Accounts payable | ($3.7M) | $101.5M | $24.7M | $114.9M |
| Contract liabilities | ($71.5M) | ($35.5M) | ($11.0M) | $12.8M |
| Other accrued expenses and liabilities | ($148.0M) | ($48.9M) | ($115.9M) | ($239.8M) |
| Other | ($172.6M) | ($166.6M) | $14.6M | $118.1M |
| Total adjustments | $912.2M | $3.2B | $1.0B | $2.8B |
| Net cash provided by (used in) operating activities | $2.7B | $3.2B | $2.8B | $2.8B |
| Purchase of property, plant, and equipment | ($875.0M) | ($1.2B) | ($1.3B) | ($1.0B) |
| Purchase of business, net of cash acquired | $0 | ($158.7M) | ($7.5M) | ($37.1M) |
| Investments in equity method investees and securities | ($18.0M) | ($35.0M) | ($34.6M) | ($30.8M) |
| Proceeds from sale of assets | $59.0M | $35.5M | $21.9M | $6.7M |
| Proceeds from sale of business | $850.5M | $409.2M | $5.4M | $96.7M |
| Other investing activities | $0 | ($11.7M) | ($2.3M) | $500.0K |
| Net cash provided by (used in) investing activities | $16.5M | ($974.8M) | ($1.3B) | ($999.4M) |
| Proceeds from issuance of long-term debt | $997.7M | $0 | $1.1B | $3.3B |
| Principal payments of long-term debt | ($1.4B) | ($957.0M) | ($809.7M) | ($2.2B) |
| Net proceeds from (repayments of) short-term borrowings | ($534.8M) | $565.3M | ($923.9M) | $842.3M |
| Dividends paid | ($715.7M) | ($731.8M) | ($653.8M) | ($587.7M) |
| Purchases of treasury stock | ($924.1M) | ($1.1B) | ($249.7M) | ($1.7B) |
| Proceeds from shares issued under equity compensation plans | 7.7M | 73.8M | 104.5M | 42.4M |
| Payments of minimum tax withholdings on stock-based payment awards | ($9.4M) | ($13.8M) | ($11.2M) | ($10.4M) |
| Payments of debt issuance, debt extinguishment, and other financing costs | ($9.0M) | ($100.0K) | ($7.7M) | ($36.2M) |
| Distributions to noncontrolling interests | ($62.5M) | ($57.5M) | — | — |
| Payment of contingent consideration | ($1.5M) | ($700.0K) | ($14.9M) | — |
| Net cash provided by (used in) financing activities | ($2.7B) | ($2.3B) | ($1.5B) | ($1.8B) |
| Effect of exchange rate changes on cash and cash equivalents | $4.8M | $100.0K | ($600.0K) | ($3.5M) |
| Net increase (decrease) in cash and cash equivalents | $34.3M | ($84.3M) | $18.9M | ($65.9M) |
| Cash and cash equivalents, beginning of year | $68.1M | $152.4M | $133.5M | $199.4M |
| Cash and cash equivalents, end of year | $102.4M | $68.1M | $152.4M | $133.5M |
| Interest, net of interest capitalized | $346.2M | $416.1M | $418.6M | $386.3M |
| Income taxes, net of refunds received | $173.6M | $197.1M | $333.5M | $129.7M |
| Additions to property, plant, and equipment | $125.2M | $143.1M | $269.6M | $183.3M |
| Line item | Aug 31, 2026 · YTD | May 31, 2026 · Q1 | Nov 30, 2025 · YTD | Aug 31, 2025 · YTD |
|---|---|---|---|---|
| Net income (loss) | $1.3B | $671.9M | $1.5B | $1.0B |
| Deferred tax provision (benefit) | $26.8M | ($78.4M) | $311.7M | $277.6M |
| Depreciation | $194.4M | $97.6M | $306.9M | $207.9M |
| Stock-based compensation | $34.9M | $15.0M | $48.0M | $32.1M |
| Noncash lease expense | $67.0M | $33.5M | $94.7M | $62.6M |
| Asset impairment and related expenses | $68.1M | $18.3M | $52.1M | $52.1M |
| Accounts receivable | ($18.2M) | ($66.4M) | $31.2M | $72.2M |
| Inventories | $3.3M | ($34.4M) | $900.0K | ($48.3M) |
| Prepaid expenses and other current assets | ($45.7M) | ($23.8M) | ($7.0M) | ($56.8M) |
| Accounts payable | $72.8M | $48.0M | ($7.9M) | $53.0M |
| Contract liabilities | $6.5M | — | ($66.6M) | ($50.4M) |
| Other accrued expenses and liabilities | ($197.9M) | ($7.2M) | ($132.5M) | ($57.0M) |
| Other | $12.4M | ($12.3M) | ($68.1M) | ($65.6M) |
| Total adjustments | $224.4M | ($10.1M) | $574.1M | $479.4M |
| Net cash provided by (used in) operating activities | $1.5B | $661.8M | $2.1B | $1.5B |
| Purchase of property, plant, and equipment | ($354.1M) | ($177.2M) | ($656.1M) | ($410.1M) |
| Purchase of business, net of cash acquired | ($15.3M) | ($15.3M) | $0 | $0 |
| Proceeds from sale of assets | $4.1M | — | $42.6M | $30.8M |
| Proceeds from sale of business | $13.9M | — | $850.6M | $851.1M |
| Other investing activities | $1.0M | ($700.0K) | $0 | $0 |
| Net cash provided by (used in) investing activities | ($350.4M) | ($193.2M) | $230.1M | $464.8M |
| Proceeds from issuance of long-term debt | $499.7M | $499.7M | $997.7M | $499.1M |
| Principal payments of long-term debt | ($602.1M) | ($601.1M) | ($1.4B) | ($902.1M) |
| Net proceeds from (repayments of) short-term borrowings | ($155.5M) | $64.4M | ($432.0M) | ($554.2M) |
| Dividends paid | ($353.8M) | ($178.7M) | ($538.8M) | ($361.1M) |
| Purchases of treasury stock | ($454.7M) | ($223.8M) | ($824.1M) | ($604.0M) |
| Payment of excise tax on share repurchases | ($8.8M) | — | — | — |
| Proceeds from shares issued under equity compensation plans | 7.3M | 3.9M | 3.1M | 3.1M |
| Payments of minimum tax withholdings on stock-based payment awards | ($10.2M) | ($10.2M) | ($9.4M) | ($9.5M) |
| Payments of debt issuance, debt extinguishment, and other financing costs | ($3.1M) | ($2.9M) | ($8.9M) | ($5.4M) |
| Distributions to noncontrolling interests | ($50.0M) | ($25.0M) | ($37.5M) | ($17.5M) |
| Payment of contingent consideration | ($300.0K) | ($300.0K) | ($1.5M) | ($1.5M) |
| Net cash provided by (used in) financing activities | ($1.1B) | ($474.0M) | ($2.3B) | ($2.0B) |
| Effect of exchange rate changes on cash and cash equivalents | ($600.0K) | ($400.0K) | $2.7M | $2.9M |
| Net increase (decrease) in cash and cash equivalents | ($3.9M) | ($5.8M) | $84.3M | $3.9M |
| Cash and cash equivalents, beginning of period | $102.4M | $102.4M | $68.1M | $68.1M |
| Cash and cash equivalents, end of period | $98.5M | $96.6M | $152.4M | $72.0M |
| Additions to property, plant, and equipment | $89.7M | $103.1M | $152.0M | $62.5M |
Constellation Brands Inc score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.